iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
AKTIENPREIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionLiberty Wealth Management Llc
Latest Disclosed Ownership3,447 shares
Latest Disclosed Value $ 582,052
Liberty Wealth Management Llc reports 0.81% decrease in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On May 12, 2026 - Liberty Wealth Management Llc filed a 13F-HR form disclosing ownership of 3,447 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $582,052 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 4, 2026 disclosing 3,475 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of -0.81% during the quarter. The current value of the position is $451,729 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F ISHARES TR ETF 464287556 3,447 -28 -0.81 582 -0.68 0.0727
2026-02-04 2025-12-31 13F ISHARES TR ETF 464287556 3,475 3 0.09 586 16.97 0.0757
2025-10-31 2025-09-30 13F ISHARES TR ETF 464287556 3,472 -107 -2.99 501 10.84 0.0706
2025-08-01 2025-06-30 13F ISHARES TR ETF 464287556 3,579 2 0.06 453 -1.09 0.0710
2025-05-12 2025-03-31 13F/A-1 ISHARES TR ETF 464287556 3,577 2 0.06 457 -3.18 0.0875
2025-05-09 2025-03-31 13F ISHARES TR ETF 464287556 3,577 2 457 0.0838
2025-02-10 2024-12-31 13F ISHARES TR ETF 464287556 3,575 -368 -9.33 473 -17.77 0.0788
2024-11-04 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,943 -27 -0.68 574 0.0975
2024-08-07 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,970 -189 -4.54 1 0.0999
2024-05-03 2024-03-31 13F ISHARES BIOTECHNOLOGY ETF ETF 464287556 4,159 193 4.87 1 0.1114
2024-02-09 2023-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,966 10 0.25 1 0.1156
2023-11-13 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,956 -94 -2.32 0 -100.00 0.1205
2023-08-10 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 4,050 0 0.00 514 -1.72 0.1270
2023-05-03 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 4,050 4 0.10 523 10.57 0.1080
2022-11-15 2022-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 4,046 0 0.00 473 -0.63 0.1261
2022-08-15 2022-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 4,046 145 3.72 476 -6.30 0.1931
2022-05-09 2022-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,901 508 -8.14 0.1833
2022-02-15 2021-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 553 -5.31 0.0240
2021-11-15 2021-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,613 2 0.06 584 -1.18 0.2083
2021-08-13 2021-06-30 13F/A-1 ISHARES TR ISHARES BIOTECH 464287556 3,611 2 0.06 591 0.68 0.2298
2021-08-13 2021-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 591,006 587,397 3,611 0.1101
2021-05-17 2021-03-31 13F ISHARES TR NASDAQ BIOTECH NASDAQ BIOTECH 464287556 3,609 0 0.00 587 0.00 0.2867
2021-02-09 2020-12-31 13F ISHARES TR NASDAQ BIOTECH NASDAQ BIOTECH 464287556 3,609 -298 -7.63 587 10.96 0.2873
2020-11-05 2020-09-30 13F ISHARES TR NASDAQ BIOTECH NASDAQ BIOTECH 464287556 3,907 -212 -5.15 529 -6.04 0.3118
2020-08-04 2020-06-30 13F ISHARES TR NASDAQ BIOTECH NASDAQ BIOTECH 464287556 4,119 206 5.26 563 33.41 0.3961
2020-04-27 2020-03-31 13F ISHARES TR NASDAQ BIOTECH NASDAQ BIOTECH 464287556 3,913 -285 -6.79 422 -16.60 0.3686
2020-02-05 2019-12-31 13F ISHARES TR NASDAQ BIOTECH NASDAQ BIOTECH 464287556 4,198 323 8.34 506 31.09 0.3987
2019-10-30 2019-09-30 13F ISHARES TR NASDAQ BIOTECH NASDAQ BIOTECH 464287556 3,875 -1,065 -21.56 386 -28.39 0.3652
2019-07-30 2019-06-30 13F ISHARES TR NASDAQ BIOTECH NASDAQ BIOTECH 464287556 4,940 953 23.90 539 21.12 0.4727
2019-04-18 2019-03-31 13F ISHARES TR NASDAQ BIOTECH NASDAQ BIOTECH 464287556 3,987 -255 -6.01 445 8.80 0.3351
2019-03-26 2018-12-31 13F ISHARES TR NASDAQ BIOTECH NASDAQ BIOTECH 464287556 4,242 4,242 409 0.3050
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.